Interleukin-8 (IL-8) belongs to a family of chemoattractant cytokines involved in chemotaxis and activation of neutrophils. As in vivo administration of 11-8 induces granulocytosis and the release of immature white blood cells into the circulation, we assessed a possible mobilizing effect of IL-8 on myeloid progenitor cells. 11-8 was administered at intraperitoneal doses ranging from 0.1 to 100 p g per mouse to female Balb/C mice (aged 8 to 12 weeks; weight, 20 to 25 g). Animals were killed at time intervals ranging from 1 to 240 minutes after IL-8 administration, and blood, bone marrow, and spleen cells were harvested. Injection of 30 p g IL-8 resulted in an increment from 25 & 9 to 418 & 299 granulocyte-macrophage colony-forming units (CFU-GM) per milliliter blood at 15 minutes after a single intraperitoneal injection. Sixty minutes after the injection of IL-8, the numbers of circulating CFU-GM per milliliter blood had almost returned to pretreatment values (82 f 39 CFU-GM per milliliter). A dose of 100 p g IL-8 per animal did not result in a further increment in the number of circulating CFU-GM. Transplantation of 5 x 10' blood-derived mononuclear cells
NTEFUEUKIN-8 (IL-8) is a chemotactic cytokine that is
involved in chemotaxis and activation of neutrophils. IL-8 was previously known as neutrophil-activating protein (NAP-1)1-5 and is a member of the c-x-c chemokine family that includes also the related ligands GROa, GROP, GROy, ENA78, NAP-2, PF4, and ~1 P 1 0 .~ These are all 70 to 90-amino acid polypeptides with 26% to 5 1 % sequence homology. The genes encoding these peptides are clustered on the human chromosome 4q13-q21.6 IL-8 is produced by a variety of cells (ie, monocytes, neutrophils, fibroblasts, endothelial cells, lung epithelial cells, mast cells, and keratin~cytesl-l~ in response to stimulation with lipopolysaccharide (LPS), tumor necrosis factor a (TNFa), granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-1, IL-2, or IL3.I4"' The in vitro bioactivities include neutrophil activation, induction of release of storage enzymes and production of toxic metabolites in neutrophil^,^^^^^^^^^ stimulation of histamine release by basophils,21*ZZ inhibition of neutrophil-endothelial interacti0n,8.'~ upregulation of CD l I b/ CD18,23,24 shedding of L -s e l e~t i n ?~.~~ and transendothelial migration of neutrophils.z6
In vivo treatment with IL-8 in monkeys, rabbits, and rats induces an instant neutropenia followed by granulocytosis, neutrophil margination and infiltration, plasma exudation, and a n g i o g e n e s i~.~.~~-~~ IL-8 levels in bronchoalveolar lavage fluid (BAL) may be used as prognostic indicators for the development of adult respiratory distress syndrome (ARDS).30,33-36 Prevention of reperfusion injury in rabbits by treatment with anti-IL-8 antibodies provides further evidence for a role of IL-8 in the pathogenesis of ARDS. 37 Previously, Jagels and H~g l i~~ reported the induction of granulocytosis in rabbits after a single injection of IL-8. Not only segmented but also immature neutrophils were mobilized, suggesting recruitment from the bone marrow reservoir. Therefore, 1L-8 seemed a suitable candidate for indue- resulted in 69% survival of lethally irradiated (8.5 Gy) recipients at 60 days versus 2 2 % for animals transplanted with an equal number of nonprimed blood-derived MNC. Transplantation of 1.5 x 10' MNC obtained from IL-8-treated donors resulted in 100% survival. Six months after transplantation, female recipients of MNC derived from IL-8-treated male donors were killed, and chimerism was determined in bone marrow, spleen, and thymus using a Y chromosomespecific probe and fluorescent in situ hybridization (FISH). The majority of bone marrow, spleen, and thymus cells (83% f 25%, 89% k 5%. and 64 It: 28%. respectively) consisted of Y chromosome-positive cells, showing that the IL-8-mobilized cells had myelolymphoid repopulating ability. We conclude that 11-8 is a cytokine that induces rapid mobilization of progenitor cells and pluripotent stem cells that are able to rescue lethally irradiated mice and that are able to completely and permanently repopulate host hematopoietic tissues. 0 1995 by The American Society of Hematology.
ing mobilization of hematopoietic progenitor cells from the bone marrow. In the present study, we investigated the mobilizing properties of IL-8 and report that a single injection induces mobilization of pluripotent stem cells that are able to provide permanent reconstitution of myeloid cells and of T and B lymphocytes.
MATERIAL AND METHODS

Animals.
Male and female Balb/c mice with an age ranging between 8 and 12 weeks were purchased from Broekman BV (Someren, The Netherlands). Animals were fed commercial rodent chow and acidified water ad libitum. In transplantation experiments, recipient animals were maintained in a pathogen-free environment and fed water containing ciprofloxacin 1 mg/mL (Bayer Nederland BV, Mijdrecht, The Netherlands), polymyxin-B 70 pg/mL, and saccharose 2 gll00 mL. In some experiments splenectomized mice were used.39 In transplantation experiments, recipient female mice were placed in a polymethylmeta-acetate (PMMA) box and given total body irradiation (8.5 Gy; Philips SL 75-516 mV linear accelerator, Philips Medical Systems, Best, The Netherlands) divided in two 2270 parts in posterior-anterior and anterior-posterior position at a dose rate of 4 Gylmin. Male, blood-derived mononuclear cells (MNC) were injected in the tail vein of lethally irradiated female recipients.
/L-8. Recombinant human IL-8 was purified from Escherichia coli expressing a synthetic gene.'' IL-8 had no colony-stimulating activity: as reported previously" and as confirmed in our laboratory (unpublished observations, March and May 1991). The concentration of endotoxin was less than 0.05 endotoxin units (EU)lmL as tested in the Limulus amoebocyte lysate assay. For in vivo experiments, IL-8 was diluted to the desired concentration in endotoxin-free phosphate-buffered saline (PBS) and administered as a single intraperitoneal injection. Polyclonal anti-IL-8 antibody, raised in goats, was from Sandoz Forschungsinstitut (Vienna, Austria), and l 0 0 pglmL of the antibody was able to neutralize an amount of 0. I pglmL IL-8, as tested in an elastase release assay.
Preparation of cell suspensions. Mice were killed by CO? asphyxia at various time intervals after IL-8 injection. Peripheral blood was drawn by cardiac puncture, and white blood cell counts were performed on a Sysmex F800 (Toa Medical Electronics CO LTD, Kobe, Japan). Manual neutrophil counts were performed after MayGrunwald-Giemsa staining. Blood derived MNC suspensions were obtained by Ficoll separation as described earlier.'" Bone marrow cells were harvested by flushing the femur under sterile conditions with RPM1 1640 containing 500 pglmL penicillin, 250 pg/mL streptomycin, and 2% fetal bovine serum (FBS: Gibco, Grand Island, NY). Single-cell suspensions of spleen and thymus cells were prepared by mashing the organs and washing once in RPM1 1640 with 5% FBS. In transplantation experiments, a fixed number of 5
x IO' blood-derived MNC from IL-8-or PBS-treated donors was suspended in PBS containing 1% syngeneic mouse serum.
GM colony-forming unit (CFU-GM) cultures. Cells were cultured as described previously?' Briefly, bone marrow cells were cultured in microtiter plates containing IO4 cells per well in semisolid medium in the presence of murine GM-CSF ( I .25 nglmL). Peripheral blood MNC and spleen cells were cultured in 3.5-cm dishes containing 5 X IO' cells per milliliter and IO6 cells per milliliter, respectively. After 6 days of culture, the number of CFU-GM (defined as aggregates of more than 20 cells) were scored using an inverted microscope.
In situ hyhridizarion. In some experiments, long-term surviving (greater than 6 months) animals were killed, bone marrow, spleen, and thymus were harvested, and single-cell suspensions were prepared. Fluorescent in situ hybridization (FISH) with a Y chromosome-specific probe was performed on single-cell suspensions as de~cribed.~' Amplification of the hybridization signal was performed according to Pinkel et al.@ Two.hundred interphase nuclei were analyzed on each slide.
Sraristical analysis. Differences were evaluated using the Student's t test. In survival analysis, differences were evaluated using the Mantel-Haenszel test for linear association. P values of less than .05 were considered statistically significant.
RESULTS
Mobilization of myeloid progenitor cells. IL-8 was administered as a single intraperitoneal injection at doses ranging from 0. I to 100 pg per mouse. Doses of 0.1, l , and IO pg IL-8 per mouse all induced neutropenia followed by granulocytosis (Fig IA) but did not mobilize hematopoietic progenitor cells into the circulation (Fig IB) . Dose levels of 30 or 100 pg IL-8 per mouse induced granulocytosis that reached maximum levels at 4 hours after injection (mean t SD neutrophil counts: 2.80 X IO" t 1.0 X IOh/mL and 3.20 X IO6 5 0.61 X I06/mL for 30 and 100 pg, respectively, v 1.35 X IO6 t 0.54 X I06/mL for saline-treated controls; n = 3 to 20 per dose per time interval; Fig IA) . At 15 minutes after injection of a dose of 30 or 1 0 0 pg IL-8, a significant (P < .001) increase in the number of circulating CFU-GM was observed from 25 t 9/mL blood at t = 0 to 418 5 299/ mL blood (30 pg) and 290 t 43/mL blood (1 00 pg) (mean t SD: seven and three experiments, respectively; 3 to 20 animals per time interval; Fig 1B) . This effect was observed between 5 and 15 minutes after administration of IL-8 and preceded the granulocytosis that developed between 1 and 4 hours after injection of IL-8. At 1 hour after injection of IL-8, the number of circulating CFU-GM returned to almost pretreatment levels (82 t 39/mL blood; mean t SD, n = 5). Subcutaneous injection of IL-8 (30 pg) resulted in a similar effect on the number of progenitor cells mobilized (397 t 178 CFU-GM/mL at t = 30 minutes: mean t SD, two experiments). Intravenous administration of 0.5 mg anti-lL-8 antibody at 1 hour before an injection of 30 pg IL-8 prevented the IL-&induced neutrophilia and mobilization of hematopoietic progenitor cells (Fig 2) , showing the IL-8 specificity of the effect. No significant changes in the numbers of progenitor cells in spleen or bone marrow were observed after injection of IL-8 ( Table l ) .
Effect ofsplenectomy on mobilization ?f CFU-GM. Accumulation of progenitor cells in the spleen may decrease their numbers in the circulation:3.u In splenectomized mice, the effect on mobilization of progenitor cells by G-CSF was threefold higher than similar treatment of intact mice.43 Therefore, we used splenectomized mice in some experiments in an attempt to increase the numbers of circulating progenitor cells after injection of IL-8. The numbers of circulating CFU-GM after a single intraperitoneal injection of IL-8 were not significantly higher in splenectomized mice. Peak numbers of circulating CFU-GM were 470 5 263/mL blood (mean 5 SD, n = 6) in splenectomized mice versus 418 -C 299/mL blood (mean 5 SD, n = 20) in intact control mice at 15 minutes after IL-8 injection. Radioprotective cnpacih of hematopoietic progenitor cells mohilized by IL-8. To study the radioprotective capacity of the circulating progenitor cells, recipient female mice were lethally irradiated (8.5 Gy) and transplanted with 5 X 10' blood-derived MNC obtained from male donors at 30 minutes after an intraperitoneal injection of saline or 30 pg of IL-8. Control recipient mice were lethally irradiated and received 1 X 10' bone marrow cells or no cells at all (irradiation controls). At 60 days after transplantation. 69% of recipients that received peripheral blood MNC (PBMNC) obtained from IL-8-treated donor animals were alive versus 22% of recipients transplanted with an equal number of PBMNC obtained from saline-treated control donor mice, showing the presence of a higher number of circulating cells with radioprotective capacity in IL-8-treated mice ( P < .05; n = 42 and n = 41, respectively; six experiments; Fig 3) . In three of six experiments, no short-term survival was observed after transplantation of PBMNC derived from salinetreated controls. In two experiments, groups of I O to 20 BalblC mice were injected intraperitoneally with 30 or 100 pg IL-8 per mouse. Controls were injected with saline (time 0). Mice were killed at 15 minutes up to 60 minutes after injection, and unseparated nucleated cells (1 x 105/mL for bone marrow and 1 x 10e/mL for splenic cells)
were plated in a CFU-GM assay. Colonies were scored after 6 days, and numbers of CFU-GM per organ were calculated. Differences in numbers of CFU-GM were not significant. lethally irradiated mice were transplanted with increasing numbers (0.15 X 10' up to 50 X 10' cells per mouse) of PBMNC derived from IL-&treated donors or from untreated control animals. Transplantation of 5 X 10' IL-8-mobilized MNC protected 70% of the lethally irradiated recipients, whereas transplantation of 1.5 X lo6 or 5 X lo6 MNC resulted in 100% radioprotection. In these experiments, none of the mice transplanted with MNC (up to 5 X lo6) of nontreated animals survived lethal irradiation (Fig 4) .
Long-term repopulating ability of IL-8-mobilized peripheral bEood cells. Six months after transplantation of IL-8-mobilized MNC, mice were killed, and chimerism of bone marrow, spleen, and thymus was assessed using a Y chromosome-specific probe and FISH. Bone marrow, spleen, and thymus contained 83% t 25%, 89% 2 5%, and 64% -C 28% Y chromosome-positive donor-derived nucleated cells, respectively (Table 2) . Cell suspensions of the thymus of control mice contain 98% T lymphocytes as assessed by immunofluorescence using a combination of monoclonal antibodies for CD4 and CD8, whereas spleen cell suspen-
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sions contain 50% B220-positive B lymphocytes. Thus, although the T cells, B cells, and myeloid cells were not separated before analysis, it is justified to state that the myeloid and both lymphoid lineages originate from transplanted donor cells due to the high percentage of donor-derived cells in these hematopoietic organs. Chimerism at 6 months after transplantation could not be assessed in recipients of PBMNC derived from saline-treated donors, as all mice died between 3 and 4 months after transplantation. Thus, these cells had no long-term repopulating ability to the extent of supporting survival.
DISCUSSION
In this study we report the stem cell-mobilizing properties of IL-8. Mice treated with a single injection of 30 or 100 pg IL-8 show a rapid increase of CFU-GM in the peripheral blood starting within 5 minutes after injection and preceding granulocytosis. The effect was specific for IL-8, as the mobilizing and neutrophilia-inducing effect was completely blocked by treatment of the animals with a polyclonal anti-IL-8 antibody before IL-8 injection. The initial neutropenia after injection of IL-8, also observed by is likely caused by pulmonary sequestratiod2,33 due to decreased deformability of the cyt~skeleton. tion, four mice were killed, and chimerism was determined using a Y chromosome-specific probe and FISH.
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related to an IL-8-induced effect on these adhesion molecules. This hypothesis would suggest the expression of IL-8 receptors on hematopoietic progenitor cells, which is at present unknown.
Another mechanism for rapid mobilization of progenitor cells would be an indirect effect involving interference with binding to matrix molecules in the marrow microenvironment. IL-8 induces mobilization as well as activation of neutrophils with the subsequent release of proteases, including gelatinase-B, elastase, and P-glucuronidase-all involved in degradation of the extracellular m a t r i~.~.~. '~-~~ In vitro studies indicate that primitive progenitor cells are preferentially bound to the extracellular matrix molecule^.^' Thus, neutrophils in the bone marrow may release gelatinase-B within 5 to 10 minutes after IL-8 inje~tion,~' resulting in nonspecific release of progenitor cells into the circulation. To investigate the involvement of gelatinase-B release in IL-8-induced stem cell mobilization, studies in rhesus monkeys are presently ongoing in our laboratory.
In the transplantation experiments, the radioprotective property of peripheral mononuclear cells mobilized by IL-8 was shown by the sharp reduced death rate between the 10th and 20th day after transplantation of 5 X lo5 cells into lethally irradiated mice, as compared with animals transplanted with MNC after saline treatment (69% survival v 22% response). Even 100% radioprotection of lethally irradiated mice was obtained after transplantation of 1.5 X lo6 MNC derived from IL-%treated donors. In addition to their radioprotective capacity, the MNC mobilized by IL-8 showed also long-term repopulating ability (LTRA). At 6 months after transplantation, the vast majority of the nucleated cells in the spleen, thymus, and bone marrow were of donor origin. Although (sub)sets of blood cells were not separated before analysis, the high percentages of donorderived cells indicate that stem cells were transplanted and capable of differentiating in the myeloid as well as in the B-and T-lymphoid lineages.
The dose of IL-8 required for stem cell mobilization is higher than that necessary for neutrophil mobilization. It should be noted that IL-8 is relatively species-specific, and, therefore, lower doses may be required in humans to obtain similar results.53 Experiments in rhesus monkeys are in progress, and, indeed, preliminary results show similar levels of circulating progenitor cells at 10-fold lower doses than used in mice (Laterveer et al, manuscript in preparation).
These results suggest that IL-8 could be a useful cytokine in the setting of peripheral stem cell transplantation. Application of IL-8 in this setting would allow elective mobilization of progenitor cells in a reproducible fashion without requiring monitoring of hematopoietic cells. This contrasts with factors like G-CSF and GM-CSF that are already used clinically for recruitment of progenitor cells but that require treatment for several Pretreatment with G-CSF or stem cell factor (SCF) may expand the pool of progenitor cells susceptible for IL-8 mobilization and may further increase the mobilizing effect of IL-8. A similar effect has been reported for the combination of G-CSF and SCF.". 56 Studies are ongoing in an attempt to further increase the IL-8-induced mobilization of progenitor cells after a short pretreatment with hematopoietic cytokines (ie, GM-CSF, G-CSF, IL-3, and SCF).
